Get the latest Science News and Discoveries

Why the FDA rejected a ‘breakthrough’ melanoma drug

The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other drug approvals

None

Related news:

The FDA Just Approved a New Depression Treatment—and It Doesn’t Involve Medication

Peptides are unproven as health aids. FDA may unleash them anyway

RFK, Jr., puts psychedelics on fast track to FDA review and approval